Shabina Ahmed, MD
Endocrinology, Diabetes & Metabolism · Bethesda, MDNPI 1023145521
Payments from drug & device makers
Across 2 payments — averaging $57.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$99
- Radius Health, Inc.$16
What the payments were for
- Food & beverage$9986%
- Education$1614%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $99 |
| Radius Health, Inc. | 1 | $16 |
How this compares
$115 in reported general payments places this provider in the 5th percentile of 235 endocrinology, diabetes & metabolism providers in Maryland.
See all endocrinology, diabetes & metabolism providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 92 | $165,492 |
| MounjaroTirzepatide | 48 | $96,005 |
| JardianceEmpagliflozin | 63 | $93,763 |
| JanuviaSitagliptin Phosphate | 60 | $71,604 |
| ProliaDenosumab | 18 | $31,417 |
| FarxigaDapagliflozin Propanediol | 16 | $26,444 |
| TradjentaLinagliptin | 18 | $25,783 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 13 | $23,657 |
| SynthroidLevothyroxine Sodium | 247 | $20,800 |
| Tresiba Flextouch U-100Insulin Degludec | 30 | $16,917 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 14 | $14,700 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $12,862 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $9,341 |
| Testosterone | 20 | $6,856 |
| Risedronate Sodium | 55 | $6,772 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Bethesda
- Michael CollinsBethesda$271K
- Michael BologneseBethesda$82K
- Thanh HoangBethesda$50K
- Mihail ZilbermintBethesda$27K
- Beatriz ChanduviBethesda$9K
- Jean ParkBaltimore$3.7M
- Michael DempseyRockville$2.7M
- Ilias SpanakisBaltimore$2.6M
- Helena RodbardRockville$2.4M
- Daniel GozziSuitland$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.